GAMCO Investors’s Charles River Laboratories CRL Stock Holding History

GAMCO Investors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,050	Closed	-$1.02M	–	864
2020 Q1	$1.02M	Buy	8,050 +50	+0.6%	+$7.5K	0.01%	543
2019 Q4	$1.22M	Buy	8,000 +1,000	+14%	+$138K	0.01%	586
2019 Q3	$927K	Hold	7,000	–	–	0.01%	613
2019 Q2	$993K	Buy	7,000 +2,000	+40%	+$271K	0.01%	609
2019 Q1	$726K	Hold	5,000	–	–	0.01%	626
2018 Q4	$566K	Sell	5,000 -2,000	-29%	-$250K	﹤0.01%	625
2018 Q3	$942K	Sell	7,000 -2,000	-22%	-$247K	0.01%	588
2018 Q2	$1.01M	Buy	9,000 +2,000	+29%	+$216K	0.01%	569
2018 Q1	$747K	Buy	7,000 +2,000	+40%	+$216K	0.01%	615
2017 Q4	$547K	Buy	+5,000	New	+$544K	﹤0.01%	671

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

GAMCO Investors's CRL Position: Q2 2020 in Review

GAMCO Investors sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 8,050 shares — an estimated $1.02M sold.

GAMCO Investors first reported a position in CRL in Q4 2017 and held it in 10 quarters. The position peaked at $1.22M in Q4 2019. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

GAMCO Investors reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
GAMCO Investors sold 8,050 Charles River Laboratories shares in Q2 2020, an estimated $1.02M.
GAMCO Investors first reported a position in Charles River Laboratories in Q4 2017 and held it in 10 quarters.
GAMCO Investors's Charles River Laboratories position peaked at $1.22M in Q4 2019.
466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on GAMCO Investors's 13F filing for Q2 2020, filed 13 Aug 2020.